Research

Managing multiple sclerosis in the COVID19 era: a review of the literature and consensus report from a panel of experts in Saudi Arabia

Amyotrophic lateral sclerosis caregiver burden and patients' quality of life during COVID-19 pandemic

Myalgia as a symptom at hospital admission by SARS-CoV-2 infection is associated to persistent musculoskeletal pain as long-term post-COVID sequelae: a case-control study

Myelopathy associated with SARS-COV-2 infection. A systematic review

Drug treatments for COVID-19: living systematic review and network meta-analysis

Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study

Prevalence, clinical characteristics and outcomes of Guillain‐Barré syndrome spectrum associated with COVID‐19: a systematic review and meta‐analysis

Neuro‐COVID frequency and short‐term outcome in the northern Portuguese population

Increased Incidence of Functional (Psychogenic) Movement Disorders in Children and Adults Amidst the COVID-19 Pandemic: A Cross-Sectional Study

Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant

mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection

High-dimensional characterization of post-acute sequalae of COVID-19

For May 2021, we have selected: Rentsch CT et al. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study. BMJ 202;372:n311. doi: 10.1136/bmj.n311.

For May 2021, we have selected: Walgaard et al. Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial. Lancet Neurol 2021; 20=:275-283. doi: 10.1016/S1474-4422(20)30494-4.

The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study